Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: About CDC.gov.

Follow HIV/AIDS

Syringe Service Program Determination of Need

Under the Consolidated Appropriation Act of 2016, federal law permits use of funds from the Department of Health and Human Services (DHHS) to support syringe service programs with the exception that funds may not be used to purchase needles or syringes. In order to use DHHS funds for this purpose, eligible state, local, tribal, and territorial health departments must first consult with CDC and provide evidence that their jurisdiction is experiencing or at risk for significant increases in hepatitis infections or an HIV outbreak due to injection drug use. The table below lists jurisdictions that have consulted CDC and have been determined to have adequately demonstrated need according to federal law, along with contact information for the point of contact regarding the determination of need for that jurisdiction.

Jurisdictions Determined to be Experiencing or At-risk of Significant Increases in Hepatitis Infection or an HIV Outbreak Due to Injection Drug Use Following CDC Consultation

This map lists jurisdictions that have consulted CDC and have been determined to have adequately demonstrated need according to federal law . These jurisdictions are experiencing or at-risk of significant increases in viral hepatitis infection or an HIV outbreak due to injection drug use. 37 states and DC, 1 tribal nation, 1 territory, 6 select counties, 1 city. There are currently 16 states/territories that have no request or determination of need pending.

37 States and DC
1 Tribal Nation
1 Territory
6 Counties
1 City

Jurisdictions Determined to be Experiencing or At-risk of Significant Increases in Hepatitis Infection or an HIV Outbreak Due to Injection Drug Use Following CDC Consultation